LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- Ningbo Qinmeng Maternal and Child Products Co., Ltd., a ...
This presentation will briefly cover point-of-care testing (POCT) from a historical standpoint. (What are we doing and why did we decide to do it this way?) This presentation will incorporate ...
Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.
Point-of-care (POC) SARS-CoV-2 tests, which can deliver results in a matter of minutes, could mark a shift away from traditional clinical diagnostic lab tests that take days to POC tests that can be ...
Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...
Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...
NEW YORK (Reuters Health) - A new 30-minute point-of-care (POC) test using self-collected vaginal swabs works as well as lab-based molecular diagnostic tests for detecting chlamydia and gonorrhea, new ...
WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results